Women's Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Women's Health Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Contraception

Oral contraceptives containing drospirenone reduce premenstrual symptoms

M. Sangthawan and S. Taneepanichskul, with King Chulalongkorn Memorial Hospital, Chulalongkorn University, Bangkok, conducted an open-label randomized study that "compared the effects of two combined oral contraceptives (OCs) containing 3 mg drospirenone (DRSP)/30 mcg ethinyl estradiol (EE) with 150 mcg levonorgestrel (LNG)/30 mcg EE on the prevalence and changes from baseline of premenstrual symptoms after six cycles."

Study subjects' "symptoms were measured using the Women's Health Assessment Questionnaire."

...

• View Other Issues of Women's Health Weekly
  
• View Other NewsRx Publications